Zapata-Gomez succeeds Holstein as Biontech CFO, BMS’s Leung retiring as general counsel

Biontech SE (NASDAQ:BNTX) named Ramón Zapata-Gomez CFO, succeeding the retiring Jens Holstein on July 1. Since 2022, Zapata-Gomez has been CFO of The Novartis Biomedical Research unit of Novartis AG (SIX:NOVN; NYSE:NVS). Prior to that position, he was CFO for Europe at the pharma’s Sandoz unit, which has since been spun out.

Cari Gallman has become EVP, general counsel and chief policy officer of Bristol Myers Squibb Co. (NYSE:BMY), succeeding Sandra “Sandy” Leung, who is retiring after more than three decades at the pharma. Gallman has been with BMS for 10 years, most recently as EVP of corporate affairs...